Medivance Inc., a Louisville, Ky.-based developer of therapeutic temperature management products for treating critically-ill patients, has raised $23 million in Series D funding. A “significant institutional investor” led the deal, and was joined by MDY Healthcare and return backers Cross Atlantic Partners, Camden Partners, Skyline Ventures and Partisan Management. Medivance has now raised around $55 million in total VC funding since its 1998 inception. www.medivance.com